Evotec
Loren Arresi is a seasoned finance professional with extensive experience in various controlling roles across multiple industries. Currently serving as a Senior Global Controller at Evotec since February 2022, Loren also holds the position of German Entity and Project Controller. Prior to this, experience includes Finance/Operations Controller at Almirall and Controller/Accountant at Archer Daniels Midland Company. Additional roles involved serving as a Referent Controller at Lufthansa Technik AG and a Junior-Controller at ALK. Loren's educational background includes a Master's degree in Manufacturing/Industrial Management from Leuphana University of Lüneburg and a Diplom in Betriebswirtschaftslehre with a focus on Accounting and Finance from the University of Hamburg.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.